Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Kihara James sold 5,401 Acadia Pharmaceuticals Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 27, 2026
On May 26, 2026, Kihara James (PRINCIPAL ACCOUNTING OFFICER) sold 5,401 Acadia Pharmaceuticals Inc. shares at US$21.18 for US$114K, leaving 24,509 shares. Filed May 27, 2026 (Form 4).
- Sold
- 5,401 shares
- Price
- US$21.18
- Value
- US$114K
- Holding after
- 24,509 shares
- Trading plan
- No
- Role
- PRINCIPAL ACCOUNTING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Sale | 5,401 | US$21.18 | 24,509 | Direct |
Source
Related
- Acadia Pharmaceuticals Inc.
- Kihara James
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Kihara James · May 5, 2026
- Form 4 · Kihara James · Apr 7, 2026
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026
- Form 4 · Harrigan Edmund · Jun 1, 2026